Skip to main content
Log in

cGMP-Dependent Protein Kinase Modulates the Sensitivity of Mesenchymal Stromal Cells to Purinergic Agonists

  • SHORT COMMUNICATION
  • Published:
Biochemistry (Moscow), Supplement Series A: Membrane and Cell Biology Aims and scope

Abstract

Calcium signaling induced by ATP in mesenchymal stromal cells (MSCs) from the human adipose tissue was studied by using the Ca2+ dye Fluo-4 and Ca2+ imaging. Previously, purinergic agonists have been found to mobilize Ca2+ in the MSC cytoplasm by stimulating IP3 production and triggering Ca2+ release from Ca2+ stores via IP3 receptors. Here we demonstrated that the phosphodiesterase inhibitor IBMX increased a lag period of ATP-induced Ca2+ responses and also shifted the dose–response curve to higher concentrations. When stimulated by ATP at doses close to the threshold concentration, MSCs became unresponsive in the presence of 50 μM IBMX. PKA inhibitor H89 did not restore MSC responsiveness to ATP lost in the presence of IBMX, while the application of KT-5823, a PKG inhibitor, canceled the inhibitory effect of IBMX. Yet, the cell treatment with KT-5823 resulted in a marked decrease in the ATP response delay. Altogether, the data obtained suggest that PKG modulates the MSC sensitivity to ATP, presumably by phosphorylating IP3 receptors in a cGMP-dependent manner.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.

Similar content being viewed by others

REFERENCES

  1. Burnstock G. 2014. Purinergic signalling: From discovery to current developments. Exp. Physiol. 99, 16–34.

    Article  CAS  PubMed  Google Scholar 

  2. Verkhratsky A., Burnstock G. 2014. Biology of purinergic signalling: Its ancient evolutionary roots, its omnipresence and its multiple functional significance. BioEssays. 36, 697–705.

    Article  CAS  PubMed  Google Scholar 

  3. Zimmermann H., Zebisch M., Strater N. 2012. Cellular function and molecular structure of ecto-nucleotidases. Purinergic Sign. 8, 437–502.

    Article  CAS  Google Scholar 

  4. Kotova P.D., Sysoeva V.Y., Rogachevskaja O.A., Bystrova M.F., Kolesnikova A.S., Tyurin-Kuzmin P.A., Fadeeva J.I., Tkachuk V.A., Kolesnikov S.S. 2014. Functional expression of adrenoreceptors in mesenchymal stromal cells derived from the human adipose tissue. Biochim. Biophys. Acta. 1843, 1899–1908.

    Article  CAS  PubMed  Google Scholar 

  5. Galle J., Hoffmann M., Krinner A. 2013. Mesenchymal stem cell heterogeneity and ageing in vitro: A model approach. In: Computational modeling in tissue engineering. Ed. Geris L. Berlin, Heidelberg: Springer, p. 183–205.

    Google Scholar 

  6. Phinney D.G. 2012. Functional heterogeneity of mesenchymal stem cells: Implications for cell therapy. J. Cell. Biochem. 113, 2806–2812.

    Article  CAS  PubMed  Google Scholar 

  7. Kotova P.D., Bystrova M.F., Rogachevskaja O.A., Khokhlov A.A., Sysoeva V.Yu., Tkachuk V.A., Kolesnikov S.S. 2018. Coupling of P2Y receptors to Ca2+ mobilization in mesenchymal stromal cells from the human adipose tissue. Cell Calcium. 71, 1–14.

    Article  CAS  PubMed  Google Scholar 

  8. Kotova P.D., Rogachevskaja O.A., Bystrova M.F., Kochkina E.N., Ivashin D.S., Kolesnikov S.S. 2018. Calcium signaling initiated by agonists in mesenchymal stromal cells from the human adipose tissue. In: Calcium and signal transduction. Ed. Buchholz J.N., London: IntechOpen, p. 139–163.

    Google Scholar 

  9. Berridge M.J., Bootman M.D., Roderick H.L. 2003. Calcium signalling: Dynamics, homeostasis and remodelling. Nat. Rev. Mol. Cell Biol. 4, 517–529.

    Article  CAS  PubMed  Google Scholar 

  10. Iino M. 2010. Spatiotemporal dynamics of Ca2+ signaling and its physiological roles. Proc. Japan Acad. Ser. B. Phys. Biol. Sci. 86, 244–256.

    Article  CAS  Google Scholar 

  11. Rios E. 2018. Calcium-induced release of calcium in muscle: 50 years of work and the emerging consensus. J. Gen. Physiol. 150, 521–537.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Berridge M.J. 2016. The inositol trisphosphate/calcium signaling pathway in health and disease. Physiol. Rev. 96, 1261–1296.

    Article  CAS  PubMed  Google Scholar 

  13. Khokhlov A.A., Romanov R.A., Zubov B.V., Pashinin A.D., Kolesnikov S.S. 2007. Light emitting diode illuminator for the microphotometric study of cells. Pribory i tekhnika eksperimenta (Rus.). 3, 128–131.

  14. Shah S.Z.A., Zhao D., Khan S.H., Yang L. 2015. Regulatory mechanisms of endoplasmic reticulum resident IP3 receptors. J. Mol. Neurosci. 56, 938–948.

    Article  CAS  PubMed  Google Scholar 

  15. Vanderheyden V., Devogelaere B., Missiaen L., De Smedt H., Bultynck G., Parys J.B. 2009. Regulation of inositol 1,4,5-trisphosphate-induced Ca2+ release by reversible phosphorylation and dephosphorylation. Biochim. Biophis. Acta 1793, 959–970.

    Article  CAS  Google Scholar 

  16. Komalavilas P., Lincoln T.M. 1994. Phosphorylation of the inositol 1,4,5-trisphosphate receptor by cyclic GMP-dependent protein kinase. J. Biol. Chem. 269, 8701–8707.

    CAS  PubMed  Google Scholar 

  17. Murthy K.S., Zhou H. 2003. Selective phosphorylation of the IP3R-I in vivo by cGMP-dependent protein kinase in smooth muscle. Am. J. Physiol. Gastr. Liver Physiol. 284, G221–G230.

    Article  CAS  Google Scholar 

  18. Soulsby M.D., Wojcikiewicz R.J. 2005. The type III inositol 1,4,5-trisphosphate receptor is phosphorylated by cAMP-dependent protein kinase at three sites. Biochem. J. 392, 493–497.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Tertyshnikova T., Yan X., Fein A. 1998. cGMP inhibits IP3-induced Ca2+ release in intact rat megakaryocytes via cGMP- and cAMP-dependent protein kinases. J. Physiol. 512, 89–96.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Ammendola A., Geiselhoringer A., Hofmann F., Schlossmann J. 2001. Molecular determinants of the interaction between the inositol 1,4,5-trisphosphate receptor-associated cGMP kinase substrate (IRAG) and cGMP kinase Iβ. J. Biol. Chem. 276, 24 153–24 159.

    Article  Google Scholar 

Download references

ACKNOWLEDGMENTS

The work was supported by the Russian Science Foundation (project no. 18-14-00347).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S. S. Kolesnikov.

Ethics declarations

Conflict of interests. The authors declare that they have no conflict of interest.

Statement of compliance with standards of research involving humans as subjects. Informed consent was obtained from all individual participants involved in the study. All procedures were performed in accordance with the order of the RF Ministry of Health of August 11, 2017, no. 517n, and according to the recommendations of the WMA Helsinki Declaration (Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects, including amendments made by the 64th Meeting of WMA in Fortaleza, Brazil, October 2013).

Additional information

Translated by A. Dunina-Barkovskaya

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kochkina, E.N., Kotova, P.D., Enukashvily, N.I. et al. cGMP-Dependent Protein Kinase Modulates the Sensitivity of Mesenchymal Stromal Cells to Purinergic Agonists. Biochem. Moscow Suppl. Ser. A 13, 283–287 (2019). https://doi.org/10.1134/S1990747819030152

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S1990747819030152

Keywords:

Navigation